Oral Cancer Exam

Our practice continually seeks advances to ensure that we are providing the optimum level of oral healthcare to our patients. We are concerned about oral cancer and screen every patient. One person in America dies from oral cancer every hour. Late detection of oral cancer is the primary cause that both the incidence and mortality rates of oral cancer continue to increase. As with most cancers, age is the primary risk factor for oral cancer. Tobacco and alcohol use are other major predisposing risk factors but more than 25% of oral cancer victims have no such lifestyle risk factors. Oral cancer risk by patient profile is as follows:

Increased risk: Patients ages 18-39 (sexually active patients; Human Papilloma Virus/16-18)
High risk: Patients age 40 and older, tobacco users (any age, within 10 years)
Highest risk: Patients age 40 and older with lifestyle risk factors (tobacco and/or alcohol use); previous history of oral cancer.

We have recently incorporated VELscope into our oral screening standard of care. We find that using VELscope for an oral cancer examination improves the ability to identify suspicious areas at their earliest stages. VELscope is similar to proven early detection procedures for other cancers such as mammography, Pap smear, and PSA and is recommended once a year by the American Cancer Society. VELscope is a simple and painless examination that gives the best chance to find any oral abnormalities at their earliest possible stage. Early detection of pre-cancerous tissue can minimize or eliminate the potentially disfiguring effects of oral cancer and possibly save your life.
The VELscope exam will be offered to you annually.


Figure 3.
Representative examples of direct visualization
under both white light and VELscope examination - photos courtesy
of the British Columbia Oral Cancer  Prevention Program.

     
 
No apparent lesion   Normal fluorescence pattern

     
 
Visible leukoplakia   Irregular, dark area visible
under fluorescence visualization.
Biopsy-confirmed severe dysplasia

     
 
No apparent lesion   Irregular, dark area visible under fluorescence visualization. Biopsy-confirmed Carcinoma in Situ (CIS) i.e. Oral Cancer